Table of Contents:
  • Recombinant vector vaccines in vaccinology / M.R. Hillerman
  • Bacterial vectors
  • Recombinant Salmonella vectors in vaccine development / R. Curtiss III [and others]
  • Use of live attenuated Salmonella for oral vaccination / S. Chatfield [and others]
  • Bacteriophages as tools for vaccine development / G.F. Hatfull [and others]
  • Viral vectors
  • Replicating and host-restricted non-replicating vaccinia virus vectors for vaccine development / B. Moss
  • Safe and effective poxvirus vectors: NYVAC and ALVAC / E. Paoletti, J. Tartaglia, J. Taylor
  • Adenovirus vectored vaccines / R.J. Natuk [and others]
  • Herpes simplex virus vectors and gene transfer to brain / J.C. Glorioso [and others]
  • Regulatory issues
  • Confirming the safety characteristics of recombinant vectors used in veterinary medicine: a regulatory perspective / C.G. Gay, H.J. Roth
  • Regulatory issues relating to the use of recombinant vectors in production of human vaccines / C.J. Marcus-Sekura
  • View on regulatory aspects of live viral vaccine safety / F. Horaud.
  • (cont) Application of viral vectors
  • Safety and immunogenicity of recombinants based on the genetically-engineered vaccinia strain, NYVAC / J. Tartaglia [and others]
  • Applications of canarypox (ALVAC) vectors in human and veterinary vaccination / J. Taylor [and others]
  • Safe and effective use of fowlpox virus as a vector for poultry vaccines / J.K. McMillen [and others]
  • Application of bacterial vectors
  • Development of recombinant Salmonellae expressing hybrid hepatitis B virus core particles as candidate oral vaccines / F. Schodel [and others]
  • Expression of human immunodeficiency virus antigens in an attenuated Salmonella typhi vector vaccine / D.M. Hone [and others]
  • Protective immunity elicited by rBCG vaccines / C.K. Stover [and others]
  • Towards new mycobacterial vaccines
  • Vaccine development
  • Human vaccines / G.L. Ada
  • Role of antigen in maintaining T cell memory / R.M. Zinkernagel
  • Molecular and cellular parameters controlling the immunogenicity of foreign B- or T-cell epitopes expressed by recombinant vectors / C. Leclerc [and others].
  • (cont) Applications of recombinant vaccinia virus for veterinary vaccines / T. Yilma
  • Future developments in recombinant vectors
  • Mucosal vaccines based on the use of cholera toxin B subunit as immunogen and antigen carrier
  • Characterization of humoral immunity after DNA injection / G.H. Rhodes [and others]
  • Introduction of foreign sequences into the genome of influenza A virus / A. Garcia-Sastre [and others].